Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
| dc.rights.license | open | en_US |
| dc.contributor.author | ELOY, Philippine | |
| dc.contributor.author | LE GRAND, Roger | |
| hal.structure.identifier | Bordeaux population health [BPH] | |
| dc.contributor.author | MALVY, Denis | |
| dc.contributor.author | GUEDJ, Jeremie | |
| dc.date.accessioned | 2022-01-14T08:48:31Z | |
| dc.date.available | 2022-01-14T08:48:31Z | |
| dc.date.issued | 2021-11-09 | |
| dc.identifier.issn | 2352-3964 | en_US |
| dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/124381 | |
| dc.language.iso | EN | en_US |
| dc.rights | Attribution 3.0 United States | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
| dc.title.en | Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two? | |
| dc.type | Article de revue | en_US |
| dc.identifier.doi | 10.1016/j.ebiom.2021.103663 | en_US |
| dc.subject.hal | Sciences du Vivant [q-bio]/Santé publique et épidémiologie | en_US |
| dc.identifier.pubmed | 34768087 | en_US |
| bordeaux.journal | EBioMedicine | en_US |
| bordeaux.volume | 74 | en_US |
| bordeaux.hal.laboratories | Bordeaux Population Health Research Center (BPH) - UMR 1219 | en_US |
| bordeaux.institution | Université de Bordeaux | en_US |
| bordeaux.institution | INSERM | en_US |
| bordeaux.team | IDLIC | en_US |
| bordeaux.peerReviewed | oui | en_US |
| bordeaux.inpress | non | en_US |
| hal.identifier | hal-03525795 | |
| hal.version | 1 | |
| hal.date.transferred | 2022-01-14T08:48:33Z | |
| hal.export | true | |
| dc.rights.cc | Pas de Licence CC | en_US |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=EBioMedicine&rft.date=2021-11-09&rft.volume=74&rft.eissn=2352-3964&rft.issn=2352-3964&rft.au=ELOY,%20Philippine&LE%20GRAND,%20Roger&MALVY,%20Denis&GUEDJ,%20Jeremie&rft.genre=article |
